Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Bortezomib is an anti-cancer agent and the first therapeutic proteasome inhibitor to be used in humans
Journal of the American Medical Association
8-tetramethyl-decahydronaphthalene-1
Smiles: CC(=O)NC1=NC2C(=CC=CC=2S1)OC1=CC(=NC=N1)C1C=CC(=CC=1)C(F)(F)F
Solubility: DMSO : 100 mg/mL (292
(S)-PF-06873600 ejasaponin IV Bortezomib is an anti-cancer agent(S) PF 06873600 it the S enantiomer of PF 06873600. PF 06873600 is a selective and orally bioavailable inhibitor of cyclin dependent kinase (CDK). Product information CAS Number: 2185859 59 8 Molecular Weight: 471. 52 Formula: C20H27F2N5O4S Chemical Name: 6 (difluoromethyl) 8 [(1S,2S) 2 hydroxy 2 methylcyclopentyl] 2 [(1 methanesulfonylpiperidin 4 yl)amino] 7H,8H pyrido[2,3 d]pyrimidin 7 one Smiles:
US$ 70.00
US$ 2550.00
US$ 71.00
US$ 125.50
US$ 155.00
US$ 69.00
US$ 69.00
US$ 56.00